Surendra Kumar Ramsanehi Sharma

Surendra Kumar Ramsanehi Sharma

Active Director Director DIN 01204773
DIN 01204773 First appointment Sep 2006 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Sep 2006
Shareholding value •••• Premium profile

About Surendra Kumar Ramsanehi Sharma

Data last updated:

Surendra Kumar Ramsanehi Sharma is a Director at Sinkhai Healthcare Limited (since 2009), Director at Shubham Specialty Products (India) Private Limited (since 2024) and Director at Shubham Laboratories (India) Private Limited (since 2024). The companies operate in Pharma and Chemicals and Materials. The 2 current companies with reported revenue have a combined latest revenue of ₹190 Cr; the largest is Sinkhai Healthcare Limited at ₹145 Cr (FY 2025). Earlier, Surendra Kumar Ramsanehi Sharma was a Whole-Time Director at Medley Pharmaceuticals Limited (2006–2023).

DIN 01204773
Primary Designation Director
Industry Pharma
First Appointment 30 Sep 2006
Oldest Company Age 21 yrs
Largest company Sinkhai Healthcare Limited · ₹145 Cr (FY 2025)
Combined revenue ₹190 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sinkhai Healthcare Limited U24230MH2005PLC151938
Director01 Jun 20092005₹145 Cr (FY 2025)Active
Director09 Dec 20242011₹45.42 Cr (FY 2025)Active
Director20 Sep 20242017Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medley Pharmaceuticals Limited U24230MH1975PLC018296
Whole-Time Director30 Sep 20061975₹1,115 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sinkhai Healthcare Limited
Shubham Specialty Products (India) Private Limited
Shubham Laboratories (India) Private Limited
Medley Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Surendra Kumar Ramsanehi Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Surendra Kumar Ramsanehi Sharma

Surendra Kumar Ramsanehi Sharma currently holds 3 directorships: Sinkhai Healthcare Limited (Director, since 01 Jun 2009, revenue ₹145 Cr (FY 2025)); Shubham Specialty Products (India) Private Limited (Director, since 09 Dec 2024, revenue ₹45.42 Cr (FY 2025)); Shubham Laboratories (India) Private Limited (Director, since 20 Sep 2024).

Surendra Kumar Ramsanehi Sharma was first appointed on 30 Sep 2006 as Whole-Time Director at Medley Pharmaceuticals Limited. The most recent appointment on record is 09 Dec 2024 at Shubham Specialty Products (India) Private Limited.

The 2 current companies of Surendra Kumar Ramsanehi Sharma that report revenue have a combined latest revenue of ₹190 Cr: Sinkhai Healthcare Limited ₹145 Cr (FY 2025); Shubham Specialty Products (India) Private Limited ₹45.42 Cr (FY 2025).

Surendra Kumar Ramsanehi Sharma held 1 earlier board appointment: Medley Pharmaceuticals Limited (Whole-Time Director, 30 Sep 2006 to 01 Apr 2023).

The current boards of Surendra Kumar Ramsanehi Sharma's companies include Ravindra Baliram More (Sinkhai Healthcare Limited), Sarosh Sami Khatib (Sinkhai Healthcare Limited), Shayaan Sarosh Khatib (Sinkhai Healthcare Limited), Ramchandra Maharshi (Shubham Specialty Products (India) Private Limited), Shubham Ramchandra Maharshi (Shubham Specialty Products (India) Private Limited), Swapnil Sanjay Nerkar (Shubham Specialty Products (India) Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available